Approximately 72% of the patients (329 of 457 patients) had been under regular surveillance for HCC performing liver ultrasonography or dynamic CT of liver and serum AFP every 6 months due to the high risk factors of HCC (ie, chronic hepatitis B infection, hepatitis C virus [HCV]-related LC, alcoholic LC). The gene discussed is AFP; the disease is laryngotracheoesophageal cleft.